Jagsonpal Pharmaceuticals Announces Dividend Recommendation Ahead of Annual General Meeting
Jagsonpal Pharmaceuticals Limited has announced a dividend recommendation for its members in light of the upcoming Annual General Meeting (AGM). The company also set the record date for determining shareholder entitlement to the dividend.The Board of Directors recommended a dividend of Rs. 4/- per equity share. This amount represents 200% and is based on the face value of Rs. 2/- per share, covering the financial year ended March 31, 2026. The recommendation was made by the company's Board of Directors during a meeting held on April 27, 2026, and is subject to shareholder approval at the ensuing AGM.
Jagsonpal Pharmaceuticals Limited has scheduled its 47th Annual General Meeting (AGM) for Friday, September 18, 2026, at 03:30 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM).
To determine the entitlement of members to this dividend, the company has fixed Friday, September 04, 2026, as the Record Date. If the Members approve the recommended dividend at the AGM, the payment is scheduled to be made within 30 days from the date of its declaration, subject to applicable taxes at source.
JAGSNPHARM Stock Price Movement
Today, shares of Jagsonpal Pharmaceuticals Limited rallied to settle at ₹230.50 in the market close, after edging up 2.20%. The equity saw robust activity, completing trading with a volume of 77,095 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.